Diagnostic Value of PET Tracers in Differentiating Glioma Tumor Recurrence from Treatment-Related Changes: A Systematic Review and Meta-Analysis
American Journal of Neuroradiology · 2025-04 · 46 (4) · 758-765
DOI: 10.3174/ajnr.a8565 ↗Kurz gefasst
Metaanalyse in der Zeitschrift American Journal of Neuroradiology, online erschienen am 02.04.2025. Verfasst von Chenchen Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Neurosurgery (C.Z.), Xi'an Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, Neoplasm Recurrence, Local, Positron-Emission Tomography. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science Fund for Distinguished Young Scholars of Shaanxi Province.
Abstract (Originalsprache)
BACKGROUND: It is often difficult to identify treatment-related changes (TRC) from tumor progression (TP) in patients with glioma, and the current application of PET scanning is expected to improve the diagnosis. PURPOSE: We used a systematic review and meta-analysis to reveal diagnostically more promising tracers by comparing the diagnostic accuracy of different PET tracers in identifying TRC and TP in patients with glioma. DATA SOURCES: We searched PubMed, Web of Science, and EMBASE databases, and we selected studies that used PET scans to identify TP and TRC in patients with glioma. STUDY SELECTION: Twenty-eight studies were identified based on the set criteria. The studies involved a total of 10 different tracers and 1405 patients. TP occurred in 67.4% (947) of patients, while TRC occurred in 32.6% (458) of patients. DATA ANALYSIS: The sensitivity, specificity, diagnostic odds ratio, positive likelihood ratio, and negative likelihood ratio of various PET tracers were calculated and summarized. Moreover, the diagnostic value of various tracers was compared. DATA SYNTHESIS: This systematic review included 28 studies comparing 10 different PET tracers, including 18F-fluoro-deoxy-glucose FDG (18F-FDG), 11C methionine (11C -MET), 18F-fuoroethyl-L-tyrosine (18F-FET), 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine (18F-FDOPA), 18F-fluorothymidine (18F-FLT), 18F-PSMA-1007, 68Ga-PSMA-11, 18F-choline (18F-CHO), 18F-fluciclovine, and [11]C-Alpha-Methyl-Tryptophan(11C-AMT). The results revealed that 11C-MET exhibited the highest diagnostic value, with an overall sensitivity and specificity of 0.89 [0.85, 0.93] and 0.91 [0.84, 0.99], respectively. Although the number of 18F-FDOPA studies is limited, it exhibited high diagnostic value, with an overall sensitivity and specificity of 1.00 [0.91, 1.00] and 0.92 [0.75, 0.99], respectively. LIMITATIONS: Most studies consisted of small sample sizes; however, the included studies differed to some extent regarding the reference standard for the final diagnosis and the standard of care. Additionally, most selected studies were retrospective. CONCLUSIONS: Amino acid-based tracers exhibited the highest diagnostic value in identifying TRC and TP in gliomas, with 11C-MET and 18F-FDOPA having the most notable advantages. Research on other new tracers is limited, therefore, further studies are needed to prove their diagnostic value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Neurosurgery (C.Z.), Xi'an Medical University, Xi'an, China.
- Department of Neurosurgery (C.Z., Y.K., W.Zhao, Z.F., Y.J., Y.Z., J.L., S.G., P.J., L.W.), Tangdu Hospital, Air Force Military Medical University, Xi'an, China.
- Department of Neurosurgery (Y.K.), Xiangyang Traditional Chinese and Western Medicine Hospital, Xiangyang, China.
- The Fourth Student Brigade of Basic Medical College (W.Zhou), Air Force Medical University, Xi'an, China.
- Department of Neurosurgery (C.Z., Y.K., W.Zhao, Z.F., Y.J., Y.Z., J.L., S.G., P.J., L.W.), Tangdu Hospital, Air Force Military Medical University, Xi'an, China drwangliang@162.com.
ORCID-Profile: Liang Wang
Förderung
- Science Fund for Distinguished Young Scholars of Shaanxi Province
Zitieren
APA
Zhou, C., Kou, Y., Zhou, W., Zhao, W., Fan, Z., Jiao, Y., Zhai, Y., Liu, J., Guo, S., Ji, P., & Wang, L. (2025). Diagnostic Value of PET Tracers in Differentiating Glioma Tumor Recurrence from Treatment-Related Changes: A Systematic Review and Meta-Analysis. American Journal of Neuroradiology, 46(4), 758-765. https://doi.org/10.3174/ajnr.a8565
Vancouver
Zhou C, Kou Y, Zhou W, Zhao W, Fan Z, Jiao Y, et al. Diagnostic Value of PET Tracers in Differentiating Glioma Tumor Recurrence from Treatment-Related Changes: A Systematic Review and Meta-Analysis. American Journal of Neuroradiology. 2025;46(4):758-765. doi:10.3174/ajnr.a8565
BibTeX
@article{Zhou2025,
author = {Zhou, Chenchen and Kou, Yunpeng and Zhou, Wenqian and Zhao, Wenjian and Fan, Zhicheng and Jiao, Yang and Zhai, Yulong and Liu, Jinghui and Guo, Shaochun and Ji, Peigang and Wang, Liang},
title = {Diagnostic Value of PET Tracers in Differentiating Glioma Tumor Recurrence from Treatment-Related Changes: A Systematic Review and Meta-Analysis},
journal = {American Journal of Neuroradiology},
year = {2025},
volume = {46},
number = {4},
pages = {758--765},
doi = {10.3174/ajnr.a8565}
}
EUVIMED